Carl Salzman removes the stigma from the much aligned benzo, reminding us of when they are essential to treatment and when they cause harm. Dr. Salzman is the past chairman of the American Psychiatric Association’s Benzodiazepine Task Force.CME: Podcast CME Post-Tests are available using this subscription (https://www.thecarlatreport.com/product/carlat-psychiatry-podcast-cme-subscription/). If you have already enrolled in that program, please log in (https://www.thecarlatreport.com/my-account/).Published On: 07/18/2022Duration: 22 minutes, 06 secondsReferenced Article: “Benzodiazepines: A Reevaluation of Their Benefits and Dangers (https://www.thecarlatreport.com/the-carlat-psychiatry-report/benzodiazepines-reevaluation-benefits-dangers/),” The Carlat Child Psychiatry Report, June 2022 Chris Aiken, MD, Kellie Newsome, PMHNP, and Carl Salzman, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

To Benzo, or not to Benzo: An Interview with Carl Salzman

Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.    
Earn CME for listening at www.thecarlatreport.com/podcastcme

Alternative Health

Health

Medicine

Science & Medicine

Health & Fitness

Mental Health

In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options. CME: Take the CME Post-Test for this EpisodePublished On: 04/15/2024Duration: 30 minutes, 43 secondNoah Capurso, MD, Brian Hurley, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Stimulant Update with Dr. Brian Hurley

Does psychiatry keep making the same mistakes? Edward Shorter gives us a historical perspective. CME: Take the CME Post-Test for this EpisodePublished On: 04/08/2024Duration: 22 minutes, 16 secondChris Aiken, MD, Edward Shorter, PhD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Controversies in Psychiatry

Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.CME: Take the CME Post-Test for this EpisodePublished On: 04/01/2024Duration: 12 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Viibryd Goes Generic

All sorts of medications are prescribed for anxiety in older adults. Today, we look at when and how to discontinue them.CME: Take the CME Post-Test for this EpisodePublished On: 03/25/2024Duration: 22 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Deprescribing Anti-anxiety Meds in Older Adults

Today we are discussing dissociative identity disorder (DID) and related topics ﻿﻿Published On: 03/18/2024Duration: 17 minutes, 31 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

To Benzo, or not to Benzo: An Interview with Carl Salzman

Download our free app to listen on your phone